162 related articles for article (PubMed ID: 17922390)
1. Serotype replacement in invasive pneumococcal disease: where do we go from here?
Hanage WP
J Infect Dis; 2007 Nov; 196(9):1282-4. PubMed ID: 17922390
[No Abstract] [Full Text] [Related]
2. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination.
Rückinger S; von Kries R; Reinert RR; van der Linden M; Siedler A
Vaccine; 2008 Jul; 26(32):3984-6. PubMed ID: 18495301
[TBL] [Abstract][Full Text] [Related]
3. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
Moraga-Llop FA
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
[No Abstract] [Full Text] [Related]
4. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
Beall B
Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
[No Abstract] [Full Text] [Related]
5. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children.
Brueggemann AB; Peto TE; Crook DW; Butler JC; Kristinsson KG; Spratt BG
J Infect Dis; 2004 Oct; 190(7):1203-11. PubMed ID: 15346329
[TBL] [Abstract][Full Text] [Related]
6. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
Kenzel S; Hufnagel M; Berner R; Henneke P
Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
[No Abstract] [Full Text] [Related]
7. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults.
Grabenstein JD
Clin Infect Dis; 2012 Jul; 55(2):255-8. PubMed ID: 22495543
[No Abstract] [Full Text] [Related]
9. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
Pletz MW; Maus U; Krug N; Welte T; Lode H
Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
[TBL] [Abstract][Full Text] [Related]
10. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of recently discovered pneumococcal serotype 6C isolates among healthy Dutch children in the pre-vaccination era.
Hermans PW; Blommaart M; Park IH; Nahm MH; Bogaert D
Vaccine; 2008 Jan; 26(4):449-50. PubMed ID: 18093702
[No Abstract] [Full Text] [Related]
12. Serotype replacement after pneumococcal vaccination.
DiNubile MJ
Lancet; 2012 Apr; 379(9824):1388; author reply 1388-9. PubMed ID: 22500870
[No Abstract] [Full Text] [Related]
13. Serotype replacement after pneumococcal vaccination.
Mulholland K; Satzke C
Lancet; 2012 Apr; 379(9824):1387; author reply 1388-9. PubMed ID: 22500869
[No Abstract] [Full Text] [Related]
14. Serotype replacement after pneumococcal vaccination.
Hausdorff WP; Van Dyke MK; Van Effelterre T
Lancet; 2012 Apr; 379(9824):1387-8; author reply 1388-9. PubMed ID: 22500868
[No Abstract] [Full Text] [Related]
15. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
Rodgers GL; Arguedas A; Cohen R; Dagan R
Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
[No Abstract] [Full Text] [Related]
16. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
Prymula R
Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
[TBL] [Abstract][Full Text] [Related]
17. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines.
Greenberg D
Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164
[No Abstract] [Full Text] [Related]
18. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
[TBL] [Abstract][Full Text] [Related]
19. Understanding the link between pneumococcal serotypes and invasive disease.
Soley C; Arguedas A
Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal resistance in the postvaccine era.
Temime L; Guillemot D; Boëlle PY
Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
